Keyphrases
B-type Natriuretic Peptide
100%
Acute Coronary Syndrome
100%
Prognosis Prediction
100%
Echocardiographic Abnormalities
100%
Cardiovascular Events
27%
Left Ventricular Hypertrophy
27%
Post-acute Coronary Syndrome
27%
Adjusted Relative Risk
18%
Type 1 Diabetes Mellitus (T1DM)
9%
Consecutive Patients
9%
Hypertension
9%
Cardiovascular Risk
9%
One-off
9%
Echocardiographic
9%
Relative Risk
9%
All-cause Mortality
9%
Smoking Status
9%
Left Ventricular Ejection Fraction
9%
Risk Prediction
9%
ST-elevation Myocardial Infarction (STEMI)
9%
Risk Stratification
9%
Renal Disease
9%
Readmission
9%
Congestive Heart Failure
9%
Near-patient
9%
Prognostic Potential
9%
Outpatient Follow-up
9%
Adverse Clinical Outcomes
9%
Medicine and Dentistry
Brain Natriuretic Peptide
100%
Acute Coronary Syndrome
100%
Cardiovascular System
36%
Left Ventricular Hypertrophy
27%
Outpatient
9%
Diabetes Mellitus
9%
Heart Left Ventricle Ejection Fraction
9%
All Cause Mortality
9%
ST Segment Elevation Myocardial Infarction
9%
Risk Stratification
9%
Congestive Heart Failure
9%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Natriuretic Peptide
100%
Acute Coronary Syndrome
100%
Heart Left Ventricle Hypertrophy
27%
All Cause Mortality
9%
Diabetes Mellitus
9%
Heart Left Ventricle Failure
9%
Congestive Heart Failure
9%
ST Segment Elevation Myocardial Infarction
9%
Biochemistry, Genetics and Molecular Biology
Brain Natriuretic Peptide
100%
All Cause Mortality
9%
ST Elevation
9%
Heart Left Ventricle Ejection Fraction
9%